Current role
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2025-05-21–present
Kyle W. Gano, Ph.D.
Board Member
Neurocrine Biosciences Inc (NBIX)Equibles does not estimate personal net worth.
Get an email with a short summary when Neurocrine Biosciences Inc publishes a filing, an earnings call transcript or a press release.
Get NBIX alertsAbout Kyle W. Gano, Ph.D.
Kyle W. Gano, Ph.D. is recorded as Board Member at Neurocrine Biosciences Inc (NBIX) since May 21, 2025. Neurocrine Biosciences Inc reported in an 8-K filed May 22, 2025 that Kyle W. Gano, Ph.D. was appointed Class II Director, effective May 21, 2025. Neurocrine Biosciences Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Neurocrine Biosciences Inc includes Kevin Gorman (CEO and Board Member), Kyle Gano, Ph.D. (CEO and Board Member), Kyle W. Gano (CEO and Board Member) and 7 others.
“The four nominees for Class II Director were elected.”
Affiliation history
-
Current
2025-05-21–present
Company network
Leadership on record at Neurocrine Biosciences Inc
- Kevin Gorman CEO, Board Member
- Kyle Gano, Ph.D. CEO, Board Member
- Kyle W. Gano CEO, Board Member
- Matthew C. Abernethy CFO
- Christine A. Poon Board Member
- Gary A. Lyons Board Member
- George J. Morrow Board Member
- Johanna Mercier Board Member
- Kevin C. Gorman Board Member
- Kevin C. Gorman, Ph.D. Board Member